ロード中...
Stroke Prevention in Atrial Fibrillation – The Use of NOACs in Everyday Clinical Practice
Non-antivitamin K oral anticoagulants (NOACs) have recently emerged as a new class of antithrombotic drugs. Four large-scale, randomised controlled trials (RCT) accredited dabigatran, rivaroxaban and edoxaban with evident advantages for stroke prevention in atrial fibrillation (AF) compared with war...
保存先:
| 出版年: | Eur Cardiol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Radcliffe Cardiology
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6159476/ https://ncbi.nlm.nih.gov/pubmed/30310429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2015.10.2.76 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|